Edition:
United Kingdom

BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

3.72USD
9:00pm BST
Change (% chg)

$-0.19 (-4.86%)
Prev Close
$3.91
Open
$3.96
Day's High
$3.96
Day's Low
$3.50
Volume
21,067
Avg. Vol
13,926
52-wk High
$27.45
52-wk Low
$3.50

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 2 0.15 0.30 0.00 0.00
Quarter Ending Dec-19 2 0.17 0.35 0.00 0.00
Year Ending Dec-19 2 0.45 0.90 0.00 16.20
Year Ending Dec-20 2 1.00 2.00 0.00 35.15
Earnings (per share)
Quarter Ending Sep-19 3 -0.65 -0.60 -0.75 -1.05
Quarter Ending Dec-19 3 -0.65 -0.60 -0.75 -1.05
Year Ending Dec-19 3 -2.55 -2.25 -2.85 -2.74
Year Ending Dec-20 3 -2.55 -2.25 -3.15 -1.16
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.41 32.67
P/E High - Last 5 Yrs. -- 147.75 47.29
P/E Low - Last 5 Yrs. -- 48.01 23.88
Beta -- 1.09 0.89
Price to Sales (TTM) -- 49.46 7.92
Price to Book (MRQ) -- 10.14 5.39
Price to Tangible Book (MRQ) -- 13.75 6.71
Price to Cash Flow (TTM) -- 55.97 24.37
% Owned Institutions -- 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.00 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.69 12.24
Sales (TTM) vs TTM 1 Yr. Ago -- 49.06 7.74
Sales - 5 Yr. Growth Rate -- 22.81 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.26 43.01
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) -- 3.59 3.03
LT Debt to Equity (MRQ) -- 18.58 10.21
Total Debt to Equity (MRQ) -- 31.20 14.56
Interest Coverage (TTM) -- -43.39 29.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.07 52.21
Gross Margin - 5 Yr. Avg. -- 60.31 50.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.44 13.16
Operating Margin (TTM) -- -184.27 6.88
Operating Margin - 5 Yr. Avg. -- -126.89 8.97
Pre-Tax Margin (TTM) -- -175.02 6.08
Pre-Tax Margin - 5 Yr. Avg. -- -132.65 9.26
Net Profit Margin (TTM) -- -181.72 2.72
Net Profit Margin - 5 Yr. Avg. -- -137.02 5.63
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,672,423 887,716,663
Net Income/Employee (TTM) -- 533,977 101,894,138
Receivable Turnover (TTM) -- 6.28 5.94
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) -- 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.42 11.18
Return on Assets - 5 Yr. Avg. -- 5.51 12.34
Return on Investment (TTM) -- 8.94 14.49
Return on Investment - 5 Yr. Avg. -- 6.84 16.03
Return on Equity (TTM) -- 10.07 15.79
Return on Equity - 5 Yr. Avg. -- 8.42 17.02
Note: Units in Millions of US Dollars

Performance for BioLine RX Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.